Pfizer (PFE) is cutting the dividend, primarily driven by their need to allocate cash for Wyeth (WYE) buyout.

The marriage between PFE and WYE is not a union of two love birds. It’s just a short term convenience driven by PFE’s need to soar the bottom line. In fact, I would send kudos to WYE management who has wrestled out good value for WYE shareholders. So why do I think it’s not a good union? continue reading rest of the article….